Phillip Capital's downgrade of Apple to reduce from neutral highlights concerns over increasing memory chip prices, which are anticipated to negatively impact the company's margins. Analyst Helena Wang pointed out that while demand for products like the iPhone 17 and MacBooks remains robust, the rising costs of memory chips are becoming a significant challenge.
Apple has managed to mitigate some of these effects through strategies such as utilizing lower-cost inventory and optimizing product mix, but these advantages are likely to wane. The DRAM market's concentration among three suppliers limits Apple's sourcing flexibility, further complicating the situation.
Following a nearly 10% drop in share price after its earnings report, where Apple exceeded revenue and earnings expectations but provided weak guidance due to a global chip shortage, the company has already raised prices on iPads and Mac models, with potential iPhone price increases on the horizon.
Additionally, regulatory challenges in Europe and China, which account for 44% of Apple's revenue, may hinder the monetization of Apple Intelligence. Despite these challenges, Wall Street remains largely optimistic, with a consensus of 32 analysts recommending a buy or strong buy rating for the stock